Tandem Investment Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Buy
23,650
+1,715
+8% +$255K 2.89% 10
2026
Q1
$3.22M Buy
21,935
+670
+3% +$103K 2.73% 13
2025
Q4
$3.29M Sell
21,265
-495
-2% -$74.1K 2.78% 10
2025
Q3
$3.03M Buy
21,760
+275
+1% +$37.2K 2.49% 13
2025
Q2
$2.9M Buy
21,485
+1,485
+7% +$201K 2.53% 13
2025
Q1
$2.92M Buy
20,000
+135
+0.7% +$19.6K 2.88% 12
2024
Q4
$2.73M Buy
+19,865
New +$2.91M 2.62% 11

Other funds holding XLV

Tandem Investment Partners's XLV Position: Q2 2026 in Review

Tandem Investment Partners increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 7.8% in Q2 2026, buying an estimated $255K and bringing the position to 23,650 shares worth $3.75M. The position accounts for 2.89% of the portfolio, ranked #10.

Tandem Investment Partners first reported a position in XLV in Q4 2024 and has held it in 7 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Tandem Investment Partners held 23,650 shares of State Street Health Care Select Sector SPDR ETF worth $3.75M as of Q2 2026.
  • Tandem Investment Partners bought 1,715 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $255K.
  • State Street Health Care Select Sector SPDR ETF made up 2.89% of Tandem Investment Partners's portfolio in Q2 2026, its #10 holding.
  • Tandem Investment Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Tandem Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.